FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $672,000 | -24.5% | 29,993 | +30.7% | 0.02% | -30.4% |
| Q1 2022 | $890,000 | -59.0% | 22,943 | -8.2% | 0.02% | -25.8% |
| Q2 2021 | $2,170,000 | -45.7% | 25,000 | -48.4% | 0.03% | -38.0% |
| Q1 2021 | $3,993,000 | -44.8% | 48,431 | -39.1% | 0.05% | -36.7% |
| Q4 2020 | $7,234,000 | +261.9% | 79,560 | +59.1% | 0.08% | +107.9% |
| Q3 2020 | $1,999,000 | +16.5% | 50,000 | 0.0% | 0.04% | -17.4% |
| Q2 2020 | $1,716,000 | +220.7% | 50,000 | +107.5% | 0.05% | +109.1% |
| Q1 2020 | $535,000 | – | 24,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |